Co-authored or featuring insights from Prevounce Health co-founder Daniel Tashnek, this article breaks down the latest CMS rulemaking regarding remote patient monitoring (RPM) device costs and what physicians need to report. It highlights regulatory compliance and cost valuation challenges under Medicare guidelines.
Prevounce Health was recognized as a notable telehealth company for its cloud software, cellular-connected Pylo devices, and services that support remote patient monitoring and chronic care management.
Prevounce Health announced that patients have transmitted over 25 million vital readings using its Pylo remote monitoring devices. This milestone highlights the company's rapid growth and the increasing adoption of its connected care solutions.
A market report highlights the growth of the digital health monitoring sector and the increasing demand for remote patient monitoring. Prevounce is noted for its Pylo GL1-LTE device, which supports diabetes management programs.
Headlines surfaced and scored by PortcoMonitor. Get the full, ranked feed + a daily briefing →